Showing results (1-10 of 12) with videos related to
Sort By:
Pageof 2
European Journal of Obstetrics, Gynecology, and Reproductive Biology|September 23, 2000
Ultrasonographic assessment of endocervix and cervical mucus in ovulatory menstrual cyclesI J Duijkers, C KlippingInternational Journal of Fertility and Menopausal Studies|November 1, 1995
Serum levels of follicle-stimulating hormone and luteinizing hormone after subcutaneous administration of human menopausal gonadotropin during pituitary suppressionI J Duijkers, Y M Magnusson, H M HollandersInternational Journal of Fertility and Menopausal Studies|November 1, 1996
Selective follicular reduction: what to do with the oocytes?P L Zusterzeel, J A Kremer, I J Duijkers, et al.International Journal of Fertility and Menopausal Studies|March 1, 1995
Patterns of serum FSH, LH and hCG after i.m. or i.v. administration of hMG during pituitary suppressionI J Duijkers, H M Hollanders, W N Willemsen, et al.Human Reproduction (Oxford, England)|November 7, 1998
Single and multiple dose pharmacokinetics and pharmacodynamics of the gonadotrophin-releasing hormone antagonist Cetrorelix in healthy female volunteersI J Duijkers, C Klipping, W N Willemsen, et al.International Journal of Fertility and Women'S Medicine|February 12, 1998
Follicular fluid hormone concentrations during controlled ovarian hyperstimulation using gonadotropin preparations with different FSH/LH ratios. I. Comparison of an FSH-dominant and a purified FSH preparationI J Duijkers, W N Willemsen, H M Hollanders, et al.European Journal of Endocrinology|July 1, 1995
Hormonal serum profiles and follicular development after intramuscular and pulsatile intravenous administration of human menopausal gonadotrophinI J Duijkers, H M Hollanders, W N Willemsen, et al.Human Reproduction (Oxford, England)|June 1, 1995
Pharmacokinetics of two human menopausal gonadotrophin preparations after single intravenous administration during pituitary suppressionI J Duijkers, M C Beerens, H J Coelingh Bennink, et al.Human Reproduction (Oxford, England)|January 22, 1998
Pharmacodynamics and pharmacokinetics after repeated subcutaneous administration of three gonadotrophin preparationsI J Duijkers, C Klipping, T M Mulders, et al.International Journal of Fertility and Women'S Medicine|December 24, 1997
Follicular fluid hormone concentrations after ovarian stimulation using gonadotropin preparations with different FSH/LH ratios. I. Comparison of an FSH-dominant and a purified FSH preparationI J Duijkers, W N Willemsen, H M Hollanders, et al.Pageof 2